Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
99 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Lacrimal Apparatus Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
Conditions: Corneal Disease;   Blepharitis;   Lacrimal Apparatus Diseases
Interventions: Device: Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml;   Device: Multifluorescence IVCM vivascope 1500 ML (Caliber/Mavig);   Procedure: microangiography
2 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
3 Recruiting Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
Conditions: Epiphora;   Conjunctivitis
Interventions: Device: Perforated Punctal plugs;   Procedure: Crawford tube insertion;   Device: Crawford lacrimal tube
4 Not yet recruiting Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye
Condition: Dry Eye Syndromes
Interventions: Device: REMOGEN OMEGA;   Device: Povidone
5 Not yet recruiting A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts
Condition: Autoimmune Diseases
Interventions: Radiation: 18F-FDG PET/CT Imaging;   Radiation: 11C-MET PET/CT Imaging;   Procedure: MRI Imaging with intravenous contrast with gadoterate meglumine;   Procedure: Minor Salivary gland (labial) biopsy
6 Not yet recruiting A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: Omega 3;   Drug: Optive Advanced;   Drug: Optive
7 Recruiting Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
8 Recruiting Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms
Conditions: Dry Eye Syndromes;   Blinking
Intervention: Device: Infrared oculography
9 Recruiting Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children
Condition: Lacrimal Duct Obstruction
Intervention: Procedure: "pushed" mono-canaliculonasal intubation
10 Not yet recruiting Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: BMS-931699;   Drug: BMS-986142;   Drug: Placebo
11 Recruiting Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
12 Not yet recruiting Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Tear Deficient Dry Eye Disease.
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
13 Recruiting Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
14 Not yet recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
15 Recruiting Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
16 Recruiting Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Conditions: Dry Eye Syndrome;   Keratoconjunctivitis Sicca
Intervention: Device: Oculeve Intranasal Neurostimulator
17 Not yet recruiting Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
Conditions: Dry Eye Syndromes;   Pterygium
Interventions: Drug: Dipyridamole;   Drug: Placebo
18 Not yet recruiting A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
Condition: Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
Interventions: Biological: MEDI7734;   Biological: Placebo
19 Recruiting Study to Evaluate the Efficacy and Safety of CKD-350
Condition: Dry Eye Syndrome
Interventions: Drug: Xenobella;   Drug: Isotonic 0.3% Sodium Hyaluronate
20 Recruiting Clinical Outcomes Following Treatment With SYSTANE® BALANCE
Condition: Dry Eye
Interventions: Other: Propylene glycol, 0.6% eye drops;   Other: Lubricant eye drops;   Other: Preservative-free 0.9% saline solution

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years